- This event has passed.
Webinar | Integrating Buprenorphine Treatment into Your Practice (National Viral Hepatitis Roundtable, Empire Liver Foundation , & HepCure)
July 13 @ 4:30 pm - 5:30 pm EDT
Integrating Buprenorphine Treatment into Your Practice: Treatment for Persons with Opioid Use Disorder & Hep C
Tuesday, July 13th, 2021 (4:30-5:30 PM EST)
NVHR – in collaboration with the Empire Liver Foundation and HepCure – is offering a webinar on Tuesday, July 13 at 4:30 pm ET on integrating buprenorphine into treatment for persons with opioid use disorder and hepatitis C.
Please join Dr. Margaret Lowenstein who will present information about using buprenorphine while treating patients with opioid use disorder in a patient-centered manner.
- Review components of buprenorphine induction and maintenance visits for patients with opioid use disorder
- Identify mechanisms to address common challenges when managing patients on buprenorphine
- Discuss ways to provide treatment for patients with opioid use disorder in a patient-centered mannerAbout Dr. Lowenstein:
Dr. Margaret (Maggie) Lowenstein is a general internist, addiction medicine physician, and an Assistant Professor of Medicine at the Perelman School of Medicine.
Dr. Lowenstein’s research focuses on novel strategies for implementing evidence-based harm reduction and treatment for opioid and other substance use disorders, particularly the use of low-barrier treatment models for opioid use disorder. She also practices integrated primary care and addiction medicine at the University of Pennsylvania and provides addiction treatment on Prevention Point Philadelphia’s mobile outreach unit.
The webinar will offer continuing education credits for clinicians, but all advocates are invited to learn more about this important topic.